KDP vs LAB · P/E 23, rev $15.35B vs rev $174.4M
Keurig Dr Pepper Inc (KDP) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported KDP revenue for 2024-12-31 was $15.35B. Net income was $1.44B. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the KDP and LAB stock pages for the full models.
Not investment advice.